Dr. Cheng Chi Chung Vincent - Clinical Microbiology and Infection
Specialist in Clinical Microbiology and Infection
Highlights
- MCHK RegisteredVerified
- Specialist in Clinical Microbiology and InfectionBachelor of Medicine and Bachelor of Surgery (MBBS) · Member of the Royal Colleges of Physicians of the United Kingdom · The Hong Kong College of Pathologists · Medical degree 1994
- InsuranceBeing compiled｜See details
About
Dr. Cheng Chi Chung Vincent is a registered Clinical Microbiology and Infection specialist in Hong Kong.
Education
Specialist in Clinical Microbiology and Infection
- Bachelor of Medicine and Bachelor of Surgery (MBBS)Bachelor of Medicine and Bachelor of Surgery (MBBS)1994
- Member of the Royal Colleges of Physicians of the United KingdomMember of the Royal Colleges of Physicians of the United Kingdom1997
Hong Kong Academy of Medicine fellowships
- FHKCPathFellow, The Hong Kong College of Pathologists
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Cheng Chi Chung Vincent? Claim page and update insurance →
FAQ
Is Dr. Cheng Chi Chung Vincent any good?
Dr. Cheng Chi Chung Vincent is a registered Clinical Microbiology and Infection specialist in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Cheng Chi Chung Vincent do?
Dr. Cheng Chi Chung Vincent practises in Clinical Microbiology and Infection.
Are you Dr. Cheng Chi Chung Vincent? Claim this page to update and manage.
ClaimResearch and publications
207 papers · 12 most recent shown
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- 2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure Prophylaxis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
- 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
- 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in Adults.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
- 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Infliximab.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
- Universal decolonization for methicillin-resistant <i>Staphylococcus aureus</i> and carbapenem-resistant <i>Acinetobacter</i> in elderly homes: A large cohort of over 16,000 residents in Hong Kong.Public health in practice (Oxford, England) · 2026
- Epidemiology and clinical characteristics of rat hepatitis E virus infection in humans.The Journal of infection · 2026
- 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
- 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Abatacept.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
- Bridging borders: adapting the Orange County methicillin-resistant <i>Staphylococcus aureus</i> decolonization protocol for an infirmary unit in Hong Kong.Infection control and hospital epidemiology · 2026
- 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Baricitinib vs. Tocilizumab.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
- Can machine learning support infection control measures by predicting carbapenemase-producing Enterobacterales colonization at admission?Infection control and hospital epidemiology · 2026
- Tracking SARS-CoV-2 RNA in the air: Lessons from a COVID-19 outbreak in an infirmary unit.American journal of infection control · 2025
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer